Phase II Pegylated Interferon

Summary

Phase II Pegylated Interferon is a clinical trial^[1].

Key Facts

• Phase II Pegylated Interferon is in the country of United States^[2].
• Phase II Pegylated Interferon's instance of is recorded as clinical trial^[3].
• Phase II Pegylated Interferon's start time is recorded as +2014-11-30T00:00:00Z^[4].
• Phase II Pegylated Interferon's end time is recorded as +2019-12-31T00:00:00Z^[5].
• Phase II Pegylated Interferon's main subject is recorded as glioma^[6].
• Phase II Pegylated Interferon's main subject is recorded as astrocytoma^[7].
• Phase II Pegylated Interferon's main subject is recorded as optic nerve glioma^[8].
• Phase II Pegylated Interferon's number of participants is recorded as {'unit': '1', 'amount': '+20'}^[9].
• Phase II Pegylated Interferon's title is recorded as A Phase II Study Of Pegylated Interferon ALFA-2b in Children With Recurrent or Refractory and Radiographically or Clinically Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas^[10].
• Phase II Pegylated Interferon's short name is recorded as Peg Interferon^[11].
• Phase II Pegylated Interferon's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+3'}^[12].
• Phase II Pegylated Interferon's ClinicalTrials.gov ID is recorded as NCT02343224^[13].
• Phase II Pegylated Interferon's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}^[14].
• Phase II Pegylated Interferon's research intervention is recorded as interferon-alpha^[15].
• Phase II Pegylated Interferon's clinical trial phase is recorded as phase II clinical trial^[16].
• Phase II Pegylated Interferon's research site is recorded as Children's Healthcare of Atlanta^[17].
• Phase II Pegylated Interferon's study type is recorded as interventional study^[18].